B7.2, PD-L1, PD-L2, or ICOS-L were constantly expressed across B7 signatures in several combinations that showed statistical relevance (Figure 1C), suggesting that they represent key players of AML immune evasion axes. Here, CD86 is linked to acute myeloid leukemia.